Systemic Inhaled Delivery Device
Inhaler
SiDD is the first pharmaceutical, multi-use inhaler customised to the patient’s respiratory ability. It is capable of quickly and effectively delivering pharmaceuticals into the bloodstream to assist in the relief of cancer treatment side effects. SiDD’s unique micro-engineered breath operated valve technology removes the need for electronics or heat, while the precise profile of the exit nozzle creates turbulent flow, aerosolization, and drug particles that are optimal for deep lung delivery. Clinical trials showed the SiDD provides systemic delivery in 2 minutes compared to 1.5 hours with a tablet.
Date of Launch
2018
Development Time
25 - 36 months
Target Regions
Europe, North America
Target Groups
Consumer / User, Specific sub-group: Cancer patients